Tachyon operates with a dedicated internal core development team and a virtual external network of expertise. We enlist the support of world-leading experts in their field, from pharmacology to manufacturing, and from science to clinical to work with us in a dynamic and fast-paced development environment. Tachyon selects from top of their class preclinical and clinical contract research organizations (CRO) and outstanding contract manufacturing organizations (CMO) to achieve one goal – advance our program with speed and innovation, without compromising the quality or integrity of our science. This highly flexible and effective model allows us to achieve our mission to bring innovative cancer drugs to patients in need as fast as possible.